查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1931230

髖關節持續被動運動裝置市場按操作模式、裝置類型、最終用戶、通路和應用分類－全球預測，2026-2032年

Hip Continuous Passive Motion Device Market by Operation Mode, Device Type, End User, Distribution Channel, Application - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 180 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2025 年髖關節持續被動運動裝置市值為 3.8487 億美元，預計到 2026 年將成長至 4.0903 億美元，年複合成長率為 5.69%，到 2032 年將達到 5.6727 億美元。

主要市場統計數據
基準年 2025 3.8487億美元
預計年份：2026年 4.0903億美元
預測年份：2032年 5.6727億美元
複合年成長率 (%) 5.69%

持續被動式髖關節運動裝置在現代醫療流程中的地位：滿足臨床需求、提高營運效率並應對不斷變化的患者期​​望

本文旨在將髖關節持續被動運動裝置定位於當今以加速復健、降低併發症發生率和提高患者自主性為核心的醫療環境中。臨床醫生和護理管理人員日益尋求能夠改善術後活動能力並最大限度減少資源負擔的干涉措施，而控制關節運動的裝置是實現這些目標的關鍵。因此，從裝置開發商到醫療服務機構的相關人員都在修訂通訊協定、採購標準和病患教育方案，將運動療法納入圍手術全期和復健流程的核心組成部分。

臨床優先事項、數位化應用和實證採購如何重新定義持續被動髖關節運動裝置的應用和創新

臨床壓力、技術成熟度和以患者為中心的護理模式的融合，正在推動該領域的變革。改進的圍手術全期通訊協定強調早期活動，以縮短住院時間並降低併發症風險。這提升了行動輔助設備在促進標準化復健方面的作用。同時，可程式設計控制系統和使用者介面的進步使得治療方案的發展更加精準，而低功耗電子元件和模組化設計則拓展了其在門診和家庭環境中的應用範圍。

評估2025年關稅調整對美國髖關節持續被動式運動裝置的採購、定價和供應鏈韌性的影響

2025年實施的關稅調整帶來的累積影響，增加了設備採購、成本結構和策略供應鏈規劃的複雜性。對於依賴跨境零件採購或成品進口的製造商和經銷商，關稅制度的改變迫使他們重新評估供應商合約、到岸成本計算和定價策略，以維持利潤率和保持競爭力。這些趨勢促使他們進行短期庫存調整和長期供應商多元化舉措。

以細分市場主導的策略，加速產品普及：協調營運模式、終端用戶需求、通路、設備架構和臨床應用。

關鍵細分分析揭示了產品屬性、分銷管道和臨床方面的差異如何塑造競爭格​​局和採購需求。從操作模式來看，區分非可程式設計設備和可程式設計設備頗具啟發意義。非可程式設計設備通常優先考慮便利性和低成本，並以交流電或電池供電的形式提供，以方便攜帶。而可程式設計設備則強調個人化治療方案和透過數位和機械介面實現的高階控制，進而影響臨床醫生的偏好和報銷管道。

區域通路和商業化工具：美洲、歐洲、中東和非洲以及亞太市場的產品和證據管道策略的區域最佳化

區域洞察凸顯了全球主要市場在需求促進因素、法規環境和商業化管道方面的差異。在美洲，醫療保健服務以整合式醫院系統、門診手術的成長以及活性化的居家醫療市場為重點，其中報銷機制和採購方整合會影響籌資策略。該地區偏好那些能夠展現營運效率和顯著術後療效的醫療器械，而與大型醫療保健系統建立策略聯盟往往能夠顯著加速產品的普及。

透過實證醫療設備、靈活的分銷策略和敏捷的生產能力實現差異化競爭，從而獲得更強大的市場地位。

對主要企業的深入分析凸顯了產品設計、臨床證據、通路佈局和服務交付的策略選擇如何決定市場定位。行業領導者透過將數據收集和遠端監控功能整合到設備中來實現差異化，從而支援療效評估並透過服務合約創建持續性收入模式。同時，其他企業則專注於模組化、低成本的平台設計，以促進租賃和所有權模式的可擴展性，從而滲透到以價值為導向的管道，例如獨立門診中心和直接面對消費者的居家醫療。

促進髖關節持續運動裝置推廣應用、確保報銷以及建構穩健的供應和分銷模式的實用策略措施

針對行業領導者的具體建議著重於使產品藍圖與支付方的期望、臨床工作流程和病患體驗要求保持一致。首先，應優先將實證實踐融入產品開發，設計前瞻性臨床項目和實用性研究，以證明產品的功能性結果和成本效益，從而為採購和報銷談判提供支援。其次，應透過直覺的介面和可靠的電源選項來提高設備的易用性，從而擴大其在家庭護理中的適用範圍，並減輕臨床人員的負擔。

採用嚴謹的混合方法調查方法，結合相關人員訪談、臨床文獻綜述、監管分析和橫斷面細分，以支持策略洞察。

我們的調查方法整合了多方面的證據基礎、相關人員訪談和定性分析，以得出可靠的實用結論。主要研究包括對臨床醫生、復健專業人員、醫院採購人員、醫療設備製造商和分銷合作夥伴進行結構化訪談，以收集有關臨床效用、購買動機和營運限制的第一手資訊。透過這些訪談，我們確定了產品設計、分銷管道特徵和證據要求的關鍵主題。

整合策略要務：證據、設計和商業性敏捷性表明，髖關節持續被動運動裝置領域的長期成功將取決於哪些因素。

總之，我們總結以下核心訊息：髖關節持續被動運動裝置正透過技術改進、實證檢驗和分銷創新，從一種小眾的術後輔助器具轉變為現代復健策略的重要組成部分。相關人員，最有可能抓住最具吸引力的機會。關稅趨勢、區域監管差異以及不斷變化的支付方期望之間的相互作用，凸顯了建立適應性強的供應鏈和製定本地化商業化計劃的必要性。

目錄

第1章：序言

第2章調查方法

  • 研究設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查前提
  • 調查限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會地圖
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章 美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

8. 依操作模式分類的髖關節持續被動運動裝置市場

  • 非可程式設備
    • 交流電源
    • 電池供電
  • 可程式裝置
    • 數位介面
    • 機械介面

9. 依設備類型分類的髖關節持續被動運動裝置市場

  • 家用設備
  • 醫院用設備

10. 依最終使用者分類的髖關節持續被動運動裝置市場

  • 門診手術中心
  • 居家醫療
  • 醫院

第11章 髖關節持續被動式運動裝置市場（依通路分類）

  • 離線
  • 線上

12. 按應用分類的髖關節持續被動式運動裝置市場

  • 慢性期管理
    • 骨關節炎管理
    • 關節炎管理
  • 損傷康復
    • 運動傷害
    • 創傷性損傷
  • 術後康復
    • 髖關節置換術
    • 全髖關節置換術

13. 髖關節持續被動式運動裝置市場（按地區分類）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 髖關節持續被動式運動裝置市場（依組別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

15. 各國髖關節持續被動式運動裝置市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

16. 美國持續被動髖關節運動裝置市場

第17章 中國髖關節連續被動式運動裝置市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • BMS
  • Breg, Inc.
  • Chattanooga International
  • Chirag Electronics Pvt. Ltd.
  • CONMED Corporation
  • DePuy Synthes
  • DJO Global, Inc.
  • HMS Medical Systems
  • India Medico Instruments
  • Kinetec
  • Medline Industries, LP
  • NC Medical Systems
  • OPED
  • OrthoRehab, Inc.
  • Physio Care Devices
  • Prasaditi Medical Equipments
  • Rimec
  • Smith & Nephew PLC
  • Stryker Corporation
  • Technomed Electronics
  • Zimmer Biomet Holdings, Inc.
  • Ossur hf.
Product Code: MRR-7B550E008DD2

The Hip Continuous Passive Motion Device Market was valued at USD 384.87 million in 2025 and is projected to grow to USD 409.03 million in 2026, with a CAGR of 5.69%, reaching USD 567.27 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 384.87 million
Estimated Year [2026] USD 409.03 million
Forecast Year [2032] USD 567.27 million
CAGR (%) 5.69%

Positioning hip continuous passive motion devices within modern care pathways to address clinical needs, operational efficiency, and evolving patient expectations

The introduction frames the contemporary relevance of hip continuous passive motion devices within a healthcare environment that prizes accelerated recovery, reduced complication rates, and enhanced patient autonomy. Clinicians and care managers increasingly seek interventions that improve postoperative mobility while minimizing resource burden, and devices that deliver controlled joint movement are central to these objectives. Consequently, stakeholders from device innovators to care delivery organizations are recalibrating protocols, procurement criteria, and patient education to incorporate motion therapy as a core component of perioperative and rehabilitative pathways.

Against this backdrop, the device landscape is evolving along multiple dimensions: technological refinement of control interfaces, diversification of power sources to enable true home use, and reorientation of distribution channels to meet the expectations of digitally enabled patients. Transitioning clinical practice patterns and payer scrutiny are raising the bar for evidence generation, usability, and cost-effectiveness. Therefore, this introduction establishes the device category as an intersection of clinical utility, engineering design, and commercial strategy, and sets the stage for a deeper examination of market forces, regulatory influences, and segmentation-driven opportunities that follow.

How clinical priorities, digital enablement, and evidence-driven procurement are redefining adoption and innovation in hip continuous passive motion devices

Transformative shifts in the landscape are driven by converging pressures from clinical practice, technology maturation, and patient-centric care models. Enhanced perioperative protocols emphasize early mobilization to reduce length of stay and lower complication risks, which elevates the role of motion devices as facilitators of standardized rehabilitation. Concurrently, advances in programmable control systems and user interfaces are enabling more precise therapy regimens, while lower-power electronics and modular designs broaden the feasibility of outpatient and home-based applications.

Moreover, reimbursement frameworks and hospital procurement are increasingly tied to demonstrable outcomes, compelling manufacturers to invest in clinical studies and integrate data capture capabilities into their devices. This shift encourages partnerships between clinical stakeholders and device developers to validate efficacy and track long-term functional outcomes. Digital enablement and remote monitoring are also redefining clinician oversight of at-home therapy, enabling adaptive protocols that respond to patient progress. Taken together, these shifts are reshaping adoption drivers, influencing product roadmaps, and creating new vectors for differentiation across design, service, and evidence generation.

Assessing how 2025 tariff adjustments altered sourcing, pricing, and supply chain resilience for hip continuous passive motion devices in the United States

The cumulative impact of tariff changes in the United States during 2025 introduced a layer of complexity to device sourcing, cost structures, and strategic supply chain planning. For manufacturers and distributors that rely on cross-border component procurement or finished goods importation, altered tariff regimes necessitated reassessments of supplier contracts, landed cost calculations, and pricing strategies to preserve margin and maintain competitive parity. These developments prompted near-term inventory adjustments and longer-term supplier diversification initiatives.

In response, manufacturers accelerated evaluation of domestic assembly options and regional manufacturing partnerships to mitigate exposure and reduce logistics lead times, while channel partners adjusted contract terms to absorb or pass through incremental costs depending on competitive positioning. At the same time, clinical purchasers and hospital supply chain teams heightened scrutiny on total cost of ownership and sought bundled service agreements that offset potential price increases. The tariff landscape therefore acted as a catalyst for more resilient sourcing strategies, reinforced the strategic importance of value-based contracting, and encouraged stakeholders to consider localization and vertical integration where feasible to protect continuity of supply and price stability.

Segment-driven strategies that align operation modes, end-user needs, distribution pathways, device architectures, and clinical applications to accelerate adoption

Key segmentation insights reveal how distinct product, channel, and clinical dimensions shape competitive dynamics and buyer requirements. When analyzing devices by operation mode, distinctions between non-programmable devices and programmable devices are instructive: non-programmable variants typically prioritize simplicity and lower cost and are available as AC-powered units and battery-operated units that support portability, while programmable devices emphasize tailored regimens and sophisticated control through digital interfaces or mechanical interfaces, influencing clinician preference and reimbursement pathways.

End-user segmentation further differentiates requirements across ambulatory surgical centers, home healthcare, and hospitals. Ambulatory surgical centers encompass both hospital-owned centers and independent centers with divergent procurement cycles and capital constraints. Home healthcare settings include direct-to-consumer rental models and professional home healthcare providers that demand robust patient support and remote monitoring. Hospitals split into general hospitals and orthopedic specialty hospitals, each imposing unique clinical workflows, volume expectations, and evidence thresholds.

Distribution channel dynamics are equally consequential, spanning direct sales, e-commerce platforms, and third-party distributors. Direct sales often route through group purchasing organization arrangements and original equipment manufacturer sales teams; e-commerce includes manufacturer online stores alongside third-party online platforms; third-party distributors range from full-line distributors to those specialized in devices. Device type delineations between home-based devices and hospital-based devices inform design trade-offs where home-based options can be owned or rental models, and hospital-based formats vary between free-standing and table-top mounted units. Finally, application segmentation across chronic management, injury rehabilitation, and postoperative rehabilitation frames clinical value propositions: chronic management addresses degenerative joint disease and osteoarthritis, injury rehabilitation covers sports and traumatic injuries, and postoperative rehabilitation encompasses hip resurfacing and total hip replacement pathways. Collectively, these segmentation lenses illuminate targeted product development, tailored go-to-market approaches, and differentiated service models that resonate with specific buyer cohorts.

Regional pathways and commercialization levers that tailor product, evidence, and channel strategies across the Americas, Europe Middle East & Africa, and Asia-Pacific markets

Regional insights underscore differentiated demand drivers, regulatory environments, and commercialization pathways across major global markets. In the Americas, healthcare delivery emphasizes integrated hospital systems, outpatient surgical growth, and an increasingly active homecare market where reimbursement and purchaser consolidation influence procurement strategies. This region tends to favor devices that demonstrate operational efficiency and clear postoperative outcome benefits, and strategic partnerships with large health systems can materially accelerate adoption.

In Europe, Middle East & Africa, fragmented reimbursement systems and diverse regulatory requirements create both challenges and opportunities; national-level health technology assessments and device registration processes influence launch sequencing, while private-sector growth in certain urban markets supports earlier uptake of innovative programmable devices. Stakeholders in this geography often prioritize robust clinical evidence and localized support infrastructure to ensure clinician confidence and patient adherence.

Asia-Pacific presents a dynamic mix of high-volume public hospital systems, expanding private care, and growing consumer demand for at-home solutions. Rapid urbanization and investments in outpatient services are enabling new distribution models, while local manufacturing and regulatory acceleration in several markets can shorten commercialization timelines. Each region therefore requires calibrated market-entry tactics, evidence generation strategies, and channel partnerships that reflect local reimbursement, clinical practice, and patient behavior patterns.

Competitive differentiation through evidence-enabled devices, adaptive distribution strategies, and manufacturing agility to strengthen market positioning

Insights on leading companies highlight how strategic choices in product design, clinical evidence, channel orchestration, and service delivery determine market positioning. Industry leaders are differentiating by integrating data capture and remote monitoring capabilities into devices to support outcome measurement and to create recurring revenue models through service contracts. Others concentrate on modular, low-cost platform designs that facilitate scale across rental and owned models, enabling penetration of value-conscious channels such as independent ambulatory centers and direct-to-consumer homecare.

Competitive advantage also emerges from distribution sophistication: some firms emphasize direct relationships with health systems and group purchasing organizations to secure preferred-supplier status, while others expand e-commerce capabilities and partnerships with specialized distributors to reach homecare and smaller hospital segments. Strategic collaborations with rehabilitation providers and payers are being used to generate real-world evidence and to support reimbursement narratives. Finally, investments in manufacturing flexibility and regional partnerships are enabling faster response to tariff dynamics and shifting demand, reinforcing supply continuity and supporting localized go-to-market strategies.

Practical strategic moves to boost adoption, secure reimbursement, and build resilient supply and distribution models for continuous motion hip devices

Actionable recommendations for industry leaders focus on aligning product roadmaps with payer expectations, clinical workflows, and patient experience imperatives. First, prioritize integration of evidence generation into product development by designing prospective clinical programs and pragmatic studies that demonstrate functional outcomes and cost-effectiveness, thereby supporting procurement and reimbursement discussions. Second, enhance device usability through intuitive interfaces and reliable power options to broaden suitability for home-based therapy and reduce the burden on clinical staff.

Third, diversify distribution by balancing direct health system engagement with scalable e-commerce models and selective third-party distributor relationships to optimize reach across hospitals, ambulatory centers, and homecare. Fourth, fortify supply chains through regional manufacturing partnerships or flexible contract manufacturing to mitigate tariff exposure and logistics disruption. Finally, develop service-led revenue streams that include rentals, remote monitoring, and support packages to create predictable lifetime value and to differentiate offerings on post-sale performance and adherence support. Executing these recommendations will accelerate adoption, strengthen commercial resilience, and improve patient outcomes.

Rigorous mixed-methods research combining stakeholder interviews, clinical literature review, regulatory analysis, and cross-sectional segmentation to underpin strategic findings

The research methodology combines a multi-source evidence base, stakeholder interviews, and qualitative analysis to ensure robust and actionable conclusions. Primary research included structured interviews with clinicians, rehabilitation specialists, hospital procurement leaders, device manufacturers, and distribution partners to capture firsthand perspectives on clinical utility, purchasing drivers, and operational constraints. These conversations informed the identification of key themes in product design, channel dynamics, and evidence needs.

Secondary analysis synthesized regulatory guidance, clinical literature, and publicly available policy documentation to contextualize clinical adoption barriers and reimbursement considerations. Comparative analysis across operation modes, end-user segments, distribution channels, device types, and applications enabled consistent mapping of needs to product and go-to-market solutions. Cross-validation with supply chain and manufacturing data provided additional rigor on sourcing and tariff-related implications. Throughout, the approach emphasized triangulation of insights to reduce bias and to highlight implications that are directly relevant to decision-makers seeking to prioritize investments and actions.

Synthesis of strategic imperatives showing how evidence, design, and commercial agility will determine long-term success in the hip continuous passive motion device category

The conclusion synthesizes the central narrative: hip continuous passive motion devices are transitioning from niche postoperative adjuncts to integral components of modern rehabilitation strategies through technological refinement, evidence-based validation, and distribution innovation. Stakeholders that align product design with clinician workflow, demonstrate measurable outcomes, and create flexible commercial models will capture the most compelling opportunities. The interplay of tariff dynamics, regional regulatory variation, and evolving payer expectations underscores the need for adaptable supply chains and localized commercialization plans.

Looking ahead, the category's future momentum will hinge on its ability to deliver both clinical benefits and operational value, to scale service-led models that enhance adherence, and to partner effectively with care providers and payers to embed devices within standardized care pathways. Firms that combine compelling clinical evidence, user-centric design, and multi-channel distribution will be best positioned to translate innovation into sustained clinical impact and commercial success.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Hip Continuous Passive Motion Device Market, by Operation Mode

  • 8.1. Non-Programmable Devices
    • 8.1.1. AC-Powered
    • 8.1.2. Battery-Operated
  • 8.2. Programmable Devices
    • 8.2.1. Digital Interface
    • 8.2.2. Mechanical Interface

9. Hip Continuous Passive Motion Device Market, by Device Type

  • 9.1. Home-Based Devices
  • 9.2. Hospital-Based Devices

10. Hip Continuous Passive Motion Device Market, by End User

  • 10.1. Ambulatory Surgical Centers
  • 10.2. Home Healthcare
  • 10.3. Hospitals

11. Hip Continuous Passive Motion Device Market, by Distribution Channel

  • 11.1. Offline
  • 11.2. Online

12. Hip Continuous Passive Motion Device Market, by Application

  • 12.1. Chronic Management
    • 12.1.1. Degenerative Joint Disease Management
    • 12.1.2. Osteoarthritis Management
  • 12.2. Injury Rehabilitation
    • 12.2.1. Sports Injuries
    • 12.2.2. Traumatic Injuries
  • 12.3. Postoperative Rehabilitation
    • 12.3.1. Hip Resurfacing
    • 12.3.2. Total Hip Replacement

13. Hip Continuous Passive Motion Device Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Hip Continuous Passive Motion Device Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Hip Continuous Passive Motion Device Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Hip Continuous Passive Motion Device Market

17. China Hip Continuous Passive Motion Device Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. BMS
  • 18.6. Breg, Inc.
  • 18.7. Chattanooga International
  • 18.8. Chirag Electronics Pvt. Ltd.
  • 18.9. CONMED Corporation
  • 18.10. DePuy Synthes
  • 18.11. DJO Global, Inc.
  • 18.12. HMS Medical Systems
  • 18.13. India Medico Instruments
  • 18.14. Kinetec
  • 18.15. Medline Industries, LP
  • 18.16. NC Medical Systems
  • 18.17. OPED
  • 18.18. OrthoRehab, Inc.
  • 18.19. Physio Care Devices
  • 18.20. Prasaditi Medical Equipments
  • 18.21. Rimec
  • 18.22. Smith & Nephew PLC
  • 18.23. Stryker Corporation
  • 18.24. Technomed Electronics
  • 18.25. Zimmer Biomet Holdings, Inc.
  • 18.26. Ossur hf.

LIST OF FIGURES

  • FIGURE 1. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY OPERATION MODE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY DEVICE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY OPERATION MODE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY NON-PROGRAMMABLE DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY NON-PROGRAMMABLE DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY NON-PROGRAMMABLE DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY NON-PROGRAMMABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY AC-POWERED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY AC-POWERED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY AC-POWERED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY BATTERY-OPERATED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY BATTERY-OPERATED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY BATTERY-OPERATED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY PROGRAMMABLE DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY PROGRAMMABLE DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY PROGRAMMABLE DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY PROGRAMMABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY DIGITAL INTERFACE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY DIGITAL INTERFACE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY DIGITAL INTERFACE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY MECHANICAL INTERFACE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY MECHANICAL INTERFACE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY MECHANICAL INTERFACE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY HOME-BASED DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY HOME-BASED DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY HOME-BASED DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY HOSPITAL-BASED DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY HOSPITAL-BASED DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY HOSPITAL-BASED DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY HOME HEALTHCARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY HOME HEALTHCARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY OFFLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY OFFLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY OFFLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY CHRONIC MANAGEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY CHRONIC MANAGEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY CHRONIC MANAGEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY CHRONIC MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY DEGENERATIVE JOINT DISEASE MANAGEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY DEGENERATIVE JOINT DISEASE MANAGEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY DEGENERATIVE JOINT DISEASE MANAGEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY OSTEOARTHRITIS MANAGEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY OSTEOARTHRITIS MANAGEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY OSTEOARTHRITIS MANAGEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY INJURY REHABILITATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY INJURY REHABILITATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY INJURY REHABILITATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY INJURY REHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY SPORTS INJURIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY SPORTS INJURIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY SPORTS INJURIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY TRAUMATIC INJURIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY TRAUMATIC INJURIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY TRAUMATIC INJURIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY POSTOPERATIVE REHABILITATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY POSTOPERATIVE REHABILITATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY POSTOPERATIVE REHABILITATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY POSTOPERATIVE REHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY HIP RESURFACING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY HIP RESURFACING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY HIP RESURFACING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY TOTAL HIP REPLACEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY TOTAL HIP REPLACEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY TOTAL HIP REPLACEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. AMERICAS HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 80. AMERICAS HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY OPERATION MODE, 2018-2032 (USD MILLION)
  • TABLE 81. AMERICAS HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY NON-PROGRAMMABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 82. AMERICAS HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY PROGRAMMABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 83. AMERICAS HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 84. AMERICAS HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 85. AMERICAS HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 86. AMERICAS HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 87. AMERICAS HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY CHRONIC MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 88. AMERICAS HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY INJURY REHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 89. AMERICAS HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY POSTOPERATIVE REHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 90. NORTH AMERICA HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. NORTH AMERICA HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY OPERATION MODE, 2018-2032 (USD MILLION)
  • TABLE 92. NORTH AMERICA HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY NON-PROGRAMMABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 93. NORTH AMERICA HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY PROGRAMMABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 94. NORTH AMERICA HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 95. NORTH AMERICA HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 96. NORTH AMERICA HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 97. NORTH AMERICA HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 98. NORTH AMERICA HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY CHRONIC MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 99. NORTH AMERICA HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY INJURY REHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 100. NORTH AMERICA HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY POSTOPERATIVE REHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 101. LATIN AMERICA HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. LATIN AMERICA HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY OPERATION MODE, 2018-2032 (USD MILLION)
  • TABLE 103. LATIN AMERICA HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY NON-PROGRAMMABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 104. LATIN AMERICA HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY PROGRAMMABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 105. LATIN AMERICA HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 106. LATIN AMERICA HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 107. LATIN AMERICA HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 108. LATIN AMERICA HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 109. LATIN AMERICA HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY CHRONIC MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 110. LATIN AMERICA HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY INJURY REHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 111. LATIN AMERICA HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY POSTOPERATIVE REHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPE, MIDDLE EAST & AFRICA HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 113. EUROPE, MIDDLE EAST & AFRICA HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY OPERATION MODE, 2018-2032 (USD MILLION)
  • TABLE 114. EUROPE, MIDDLE EAST & AFRICA HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY NON-PROGRAMMABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 115. EUROPE, MIDDLE EAST & AFRICA HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY PROGRAMMABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 116. EUROPE, MIDDLE EAST & AFRICA HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 117. EUROPE, MIDDLE EAST & AFRICA HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 118. EUROPE, MIDDLE EAST & AFRICA HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 119. EUROPE, MIDDLE EAST & AFRICA HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 120. EUROPE, MIDDLE EAST & AFRICA HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY CHRONIC MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPE, MIDDLE EAST & AFRICA HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY INJURY REHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 122. EUROPE, MIDDLE EAST & AFRICA HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY POSTOPERATIVE REHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 123. EUROPE HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPE HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY OPERATION MODE, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPE HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY NON-PROGRAMMABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPE HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY PROGRAMMABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPE HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPE HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPE HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY CHRONIC MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY INJURY REHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY POSTOPERATIVE REHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 134. MIDDLE EAST HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 135. MIDDLE EAST HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY OPERATION MODE, 2018-2032 (USD MILLION)
  • TABLE 136. MIDDLE EAST HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY NON-PROGRAMMABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 137. MIDDLE EAST HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY PROGRAMMABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 138. MIDDLE EAST HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 139. MIDDLE EAST HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 140. MIDDLE EAST HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 141. MIDDLE EAST HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 142. MIDDLE EAST HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY CHRONIC MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 143. MIDDLE EAST HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY INJURY REHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 144. MIDDLE EAST HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY POSTOPERATIVE REHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 145. AFRICA HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 146. AFRICA HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY OPERATION MODE, 2018-2032 (USD MILLION)
  • TABLE 147. AFRICA HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY NON-PROGRAMMABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 148. AFRICA HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY PROGRAMMABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 149. AFRICA HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 150. AFRICA HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 151. AFRICA HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 152. AFRICA HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 153. AFRICA HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY CHRONIC MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 154. AFRICA HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY INJURY REHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 155. AFRICA HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY POSTOPERATIVE REHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 156. ASIA-PACIFIC HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 157. ASIA-PACIFIC HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY OPERATION MODE, 2018-2032 (USD MILLION)
  • TABLE 158. ASIA-PACIFIC HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY NON-PROGRAMMABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 159. ASIA-PACIFIC HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY PROGRAMMABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 160. ASIA-PACIFIC HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 161. ASIA-PACIFIC HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 162. ASIA-PACIFIC HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 163. ASIA-PACIFIC HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 164. ASIA-PACIFIC HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY CHRONIC MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 165. ASIA-PACIFIC HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY INJURY REHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 166. ASIA-PACIFIC HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY POSTOPERATIVE REHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 167. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 168. ASEAN HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 169. ASEAN HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY OPERATION MODE, 2018-2032 (USD MILLION)
  • TABLE 170. ASEAN HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY NON-PROGRAMMABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 171. ASEAN HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY PROGRAMMABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 172. ASEAN HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 173. ASEAN HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 174. ASEAN HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 175. ASEAN HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 176. ASEAN HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY CHRONIC MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 177. ASEAN HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY INJURY REHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 178. ASEAN HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY POSTOPERATIVE REHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 179. GCC HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 180. GCC HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY OPERATION MODE, 2018-2032 (USD MILLION)
  • TABLE 181. GCC HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY NON-PROGRAMMABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 182. GCC HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY PROGRAMMABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 183. GCC HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 184. GCC HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 185. GCC HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 186. GCC HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 187. GCC HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY CHRONIC MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 188. GCC HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY INJURY REHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 189. GCC HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY POSTOPERATIVE REHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 190. EUROPEAN UNION HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 191. EUROPEAN UNION HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY OPERATION MODE, 2018-2032 (USD MILLION)
  • TABLE 192. EUROPEAN UNION HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY NON-PROGRAMMABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 193. EUROPEAN UNION HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY PROGRAMMABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 194. EUROPEAN UNION HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 195. EUROPEAN UNION HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 196. EUROPEAN UNION HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 197. EUROPEAN UNION HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 198. EUROPEAN UNION HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY CHRONIC MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 199. EUROPEAN UNION HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY INJURY REHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 200. EUROPEAN UNION HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY POSTOPERATIVE REHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 201. BRICS HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 202. BRICS HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY OPERATION MODE, 2018-2032 (USD MILLION)
  • TABLE 203. BRICS HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY NON-PROGRAMMABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 204. BRICS HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY PROGRAMMABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 205. BRICS HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 206. BRICS HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 207. BRICS HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 208. BRICS HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 209. BRICS HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY CHRONIC MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 210. BRICS HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY INJURY REHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 211. BRICS HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY POSTOPERATIVE REHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 212. G7 HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 213. G7 HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY OPERATION MODE, 2018-2032 (USD MILLION)
  • TABLE 214. G7 HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY NON-PROGRAMMABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 215. G7 HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY PROGRAMMABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 216. G7 HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 217. G7 HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 218. G7 HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 219. G7 HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 220. G7 HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY CHRONIC MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 221. G7 HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY INJURY REHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 222. G7 HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY POSTOPERATIVE REHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 223. NATO HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 224. NATO HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY OPERATION MODE, 2018-2032 (USD MILLION)
  • TABLE 225. NATO HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY NON-PROGRAMMABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 226. NATO HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY PROGRAMMABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 227. NATO HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 228. NATO HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 229. NATO HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 230. NATO HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 231. NATO HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY CHRONIC MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 232. NATO HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY INJURY REHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 233. NATO HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY POSTOPERATIVE REHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 234. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 235. UNITED STATES HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 236. UNITED STATES HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY OPERATION MODE, 2018-2032 (USD MILLION)
  • TABLE 237. UNITED STATES HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY NON-PROGRAMMABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 238. UNITED STATES HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY PROGRAMMABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 239. UNITED STATES HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 240. UNITED STATES HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 241. UNITED STATES HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 242. UNITED STATES HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 243. UNITED STATES HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY CHRONIC MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 244. UNITED STATES HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY INJURY REHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 245. UNITED STATES HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY POSTOPERATIVE REHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 246. CHINA HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 247. CHINA HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY OPERATION MODE, 2018-2032 (USD MILLION)
  • TABLE 248. CHINA HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY NON-PROGRAMMABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 249. CHINA HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY PROGRAMMABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 250. CHINA HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 251. CHINA HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 252. CHINA HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 253. CHINA HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 254. CHINA HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY CHRONIC MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 255. CHINA HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY INJURY REHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 256. CHINA HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY POSTOPERATIVE REHABILITATION, 2018-2032 (USD MILLION)